Kailera Therapeutics, Inc.
KLRANasdaqCIK 2096997HealthcareFiscal year ends Dec 31
Reports and events: 9 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1216:29 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-346958 |
| 2026-08-1216:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-346919 |
| 2026-05-2616:29 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-239417 |
| 2026-05-2616:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-239362 |
| 2026-04-2320:01 ET | SCHEDULE 13D | Ownership report, active investor | 0001193125-26-174330 |
| 2026-04-2319:34 ET | SCHEDULE 13D | Ownership report, active investor | 0001193125-26-174293 |
| 2026-04-2016:19 ET | 8-K | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-164040 |
| 2026-04-1306:12 ET | S-1/A | Registration statement, amended | 0001193125-26-151904 |
| 2026-03-2716:02 ET | S-1 | Registration statement | 0001193125-26-128952 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. Listed shows no prices and gives no investment advice.